12/3
04:31 pm
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/30
10:53 pm
lmat
Is LeMaitre Vascular's Drop an Opportunity After Expansion and Regulatory News? [Yahoo! Finance]
Low
Report
Is LeMaitre Vascular's Drop an Opportunity After Expansion and Regulatory News? [Yahoo! Finance]
11/30
06:22 pm
lmat
LeMaitre Vascular (LMAT): A Fresh Look at Valuation After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
LeMaitre Vascular (LMAT): A Fresh Look at Valuation After Recent Share Price Weakness [Yahoo! Finance]
11/27
02:50 pm
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
02:02 pm
lmat
LeMaitre Vascular (NASDAQ:LMAT) was downgraded by analysts at
Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) was downgraded by analysts at
Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating.
11/15
07:05 pm
lmat
LeMaitre Vascular (NASDAQ:LMAT) Could Be A Buy For Its Upcoming Dividend [Yahoo! Finance]
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) Could Be A Buy For Its Upcoming Dividend [Yahoo! Finance]
11/14
07:08 pm
lmat
3 Russell 2000 Stocks Walking a Fine Line [Yahoo! Finance]
Low
Report
3 Russell 2000 Stocks Walking a Fine Line [Yahoo! Finance]
11/12
04:53 pm
lmat
LeMaitre to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
LeMaitre to Participate in Upcoming Investor Conferences [Yahoo! Finance]
11/12
04:13 pm
lmat
LeMaitre to Participate in Upcoming Investor Conferences
Low
Report
LeMaitre to Participate in Upcoming Investor Conferences
11/11
07:17 am
lmat
LeMaitre Vascular (NASDAQ:LMAT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/10
11:09 am
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.
11/8
09:16 am
lmat
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]
Low
Report
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]
11/7
02:22 pm
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its price target lowered by analysts at Wells Fargo & Company from $97.00 to $93.00. They now have an "equal weight" rating on the stock.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its price target lowered by analysts at Wells Fargo & Company from $97.00 to $93.00. They now have an "equal weight" rating on the stock.
11/7
12:35 am
lmat
LeMaitre Vascular declares $0.20 dividend [Seeking Alpha]
Medium
Report
LeMaitre Vascular declares $0.20 dividend [Seeking Alpha]
11/6
04:05 pm
lmat
LeMaitre Q3 2025 Financial Results
Low
Report
LeMaitre Q3 2025 Financial Results
11/5
12:56 pm
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "buy" rating reaffirmed by analysts at Roth Capital. They now have a $108.00 price target on the stock.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "buy" rating reaffirmed by analysts at Roth Capital. They now have a $108.00 price target on the stock.
10/15
08:12 am
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
10/9
05:53 pm
lmat
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
Low
Report
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
10/6
09:21 am
lmat
LeMaitre Vascular (LMAT): Unpacking Current Valuation After Steady Share Performance [Yahoo! Finance]
Low
Report
LeMaitre Vascular (LMAT): Unpacking Current Valuation After Steady Share Performance [Yahoo! Finance]
9/25
04:10 am
lmat
1 Profitable Stock with Solid Fundamentals and 2 We Ignore [Yahoo! Finance]
Medium
Report
1 Profitable Stock with Solid Fundamentals and 2 We Ignore [Yahoo! Finance]
9/23
11:51 am
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
9/19
05:30 am
lmat
3 Low-Volatility Stocks We Find Risky [Yahoo! Finance]
Low
Report
3 Low-Volatility Stocks We Find Risky [Yahoo! Finance]
9/11
11:35 am
lmat
LeMaitre Vascular, Inc. (LMAT) Gains Edge in Niche Vascular Device Market [Yahoo! Finance]
Low
Report
LeMaitre Vascular, Inc. (LMAT) Gains Edge in Niche Vascular Device Market [Yahoo! Finance]